Overview
Emile Loria is a co-founder and board member of Dendrogenix, a position he has held since 2018. He is based in Brussels.
Between 2010 and December 2019 he was chairman, founder and investor at Portable Genomics, Inc. From 2006 to 2013 he was managing director of MS Medical Synergy and, over the same period, worked as a consultant to Onxeo. Earlier, he was president and chief executive of Epimmune from January 2001 to December 2005, and president and chief executive of Biovector Therapeutics from 1994 to 2000.
He studied at Paris-Sud University (Paris XI) from 1973 to 1979, obtaining a Doctor of Medicine degree.
Career history
Related profiles
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.